Medical information
12 articles shown
Is Thyroid Cancer a Head and Neck Cancer? Understanding Diagnosis and Treatment
Anatomically the thyroid sits in the neck, so in a broad sense it belongs to the head and neck region, but in practice thyroid cancer behaves so differently from cancers of the mouth, pharynx, and larynx that it is usually managed separately. Papillary and follicular cancers, which make up most cases, tend to grow slowly with a good outlook. Diagnosis relies on ultrasound and fine-needle aspiration, and treatment centers on surgery and radioactive iodine.
When They Say Triple-Negative Breast Cancer Is Tricky, What Does It Mean?
Triple-negative breast cancer is the type where all three markers - ER, PR, and HER2 - are negative, accounting for about ten to fifteen percent of cases. The core of why it is called tricky is having few targets to aim at, like anti-hormone or HER2 therapy - it does not mean there is no treatment. Options such as immunotherapy, antibody-drug conjugates (ADCs), and PARP inhibitors for BRCA mutations are widening, and the course differs by tumor characteristics and stage even under the same label.
Multiple Myeloma: The Blood Cancer That Weakens Bone — Symptoms and the Path of Treatment
Multiple myeloma is a blood cancer in which plasma cells in the bone marrow multiply abnormally, weakening bone and causing anemia, kidney strain, and high calcium. Diagnosis combines blood and urine tests, a marrow biopsy, and imaging, and it is treated as a long-term disease using targeted drugs, immunomodulators, and stem cell transplant.
How Much of the Stomach Comes Out in Surgery: Partial vs. Total Gastrectomy
The extent of stomach cancer surgery is set by the tumor's location and spread. A lower or middle tumor calls for a partial (subtotal) removal of about two-thirds of the stomach, while a tumor near the upper inlet or in several spots leads to a total gastrectomy. Total removal usually requires vitamin B12 replacement, and both call for eating small amounts often.
HER2-Positive Breast Cancer: Who Gets Targeted Therapy, and Why?
HER2-positive breast cancer overexpresses the HER2 protein and accounts for roughly one in five cases. Targeted drugs such as trastuzumab (Herceptin), pertuzumab, and T-DM1 attack HER2 directly to improve outcomes. Eligibility is set by biopsy (IHC 3+ or FISH-positive), and some of these drugs require heart-function monitoring.
Lung Cancer Staging: What the Numbers Tell You, and What Comes Next in Treatment
Lung cancer staging combines tumor size (T), lymph node involvement (N), and metastasis (M) into stages 1 through 4 — a kind of map of where the cancer stands inside your body. Even at the same stage, the details and the type of cancer (non-small cell vs. small cell) steer treatment toward surgery, radiation, or drug therapy, and the stage itself can be reassessed as treatment progresses.
Lung Cancer Without Ever Smoking? Causes and Testing for Non-Smokers
Lung cancer can develop even if you've never smoked. Environmental factors like secondhand smoke, radon, and occupational exposure, along with gene mutations such as EGFR and ALK, are the main culprits, and early on there are almost no symptoms. It's confirmed with low-dose chest CT and tissue and genetic testing, and if you have risk factors, it's wise to discuss screening timing with your doctor in advance.
Starting immunotherapy for lung cancer (immune checkpoint inhibitors): what's worth knowing first
A patient-friendly rundown of how immune checkpoint inhibitors for lung cancer work, why PD-L1 and genetic testing matters before treatment, and what to expect from immune-related side effects and the phenomenon of pseudoprogression.
Targeted Therapy for Lung Cancer — EGFR, ALK, and the Wall Called Resistance
Lung cancers with EGFR or ALK mutations can be treated with targeted pills, but over time resistance sets in and the drug stops working. Even then, doctors can re-check the mutation and switch to a next-generation drug, making it possible to keep treatment going as a long-term battle.
Same Name, Two Diseases: Why Lung Cancer Is Split Into Non-Small Cell and Small Cell
Lung cancer is divided into non-small cell and small cell types based on how the cancer cells look. Small cell cancer spreads quickly and is treated mainly with drugs and radiation, while non-small cell cancer grows more slowly and can often be removed by surgery when caught early. Non-small cell cancer in particular relies on genetic-mutation and immune-marker testing to decide on targeted or immunotherapy, so this distinction shapes the whole treatment plan.
Low-Dose Chest CT: Who Actually Needs Lung Cancer Screening?
Low-dose chest CT is a screening test aimed at finding lung cancer before symptoms appear in high-risk people over 50 who have smoked for years. It catches smaller nodules than an X-ray but produces frequent false positives that require follow-up, and it isn't recommended for non-smokers. Screening is no substitute for quitting smoking.
Why does the same throat cancer heal well for one person but not another - the story of HPV-positive and HPV-negative oropharyngeal cancer
The course of oropharyngeal cancer differs greatly depending on whether HPV is involved. Even at the same stage, HPV-positive cases generally show better treatment response and survival, which is why staging is now classified separately for the two. Still, heavy long-term smoking erodes that advantage, and even HPV-negative cancers can have good outcomes when caught and treated early. The key is to confirm your tumor's HPV status and risk factors with your doctor.